@article {Holt2021.03.27.21254452, author = {Hayley Holt and Mohammad Talaei and Matthew Greenig and Dominik Zenner and Jane Symons and Clare Relton and Katherine S Young and Molly R Davies and Katherine N Thompson and Jed Ashman and Sultan Saeed Rajpoot and Ahmed Ali Kayyale and Sarah El Rifai and Philippa J. Lloyd and David A. Jolliffe and Sarah Finer and Stamatina Ilidriomiti and Alec Miners and Nicholas S. Hopkinson and Bodrul Alam and Paul E Pfeffer and David McCoy and Gwyneth A Davies and Ronan A Lyons and Christopher J Griffiths and Frank Kee and Aziz Sheikh and Gerome Breen and Seif O Shaheen and Adrian R Martineau}, title = {Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK)}, elocation-id = {2021.03.27.21254452}, year = {2021}, doi = {10.1101/2021.03.27.21254452}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Risk factors for severe COVID-19 include older age, male sex, obesity, Black or Asian ethnicity and underlying medical conditions. Whether these factors also influence susceptibility to developing COVID-19 is uncertain.Methods We undertook a prospective, population-based cohort study (COVIDENCE UK) from 1st May 2020 to 5th February 2021. Baseline information on potential risk factors was captured by an online questionnaire. Monthly follow-up questionnaires captured incident COVID-19. We used logistic regression models to estimate multivariable-adjusted odds ratios (aORs) for associations between potential risk factors and risk of COVID-19.Findings We recorded 446 incident cases of COVID-19 in 15,227 participants (2.9\%). Increased risk of developing COVID-19 was independently associated with Asian/Asian British vs. White ethnicity (aOR 2.31, 95\% CI 1.35-3.95), household overcrowding (aOR per additional 0.5 people/bedroom 1.26, 1.11-1.43), any vs. no visits to/from other households in previous week (aOR 1.33, 1.07-1.64), number of visits to indoor public places (aOR per extra visit per week 1.05, 1.01-1.09), frontline occupation excluding health/social care vs. no frontline occupation (aOR 1.49, 1.12-1.98), and raised body mass index (BMI) (aOR 1.51 [1.20-1.90] for BMI 25.0-30.0 kg/m2 and 1.38 [1.05-1.82] for BMI \>30.0 kg/m2 vs. BMI \<25.0 kg/m2). Atopic disease was independently associated with decreased risk (aOR 0.76, 0.59-0.98). No independent associations were seen for age, sex, other medical conditions, diet, or micronutrient supplement use.Interpretation After rigorous adjustment for factors influencing exposure to SARS-CoV-2, Asian/Asian British ethnicity and raised BMI were associated with increased risk of developing COVID-19, while atopic disease was associated with decreased risk.Funding Barts Charity, Health Data Research UKCompeting Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04330599Funding StatementThis study was supported by a grant from Barts Charity to ARM and CJG (ref MGU0466). The work was carried out with the support of BREATHE - The Health Data Research Hub for Respiratory Health [MC_PC_19004] in partnership with SAIL Databank. BREATHE is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by Leicester South Research Ethics Committee, UK (ref 20/EM/0117).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesA copy of anonymised data will be made available following publication of this manuscript in a peer-reviewed journal}, URL = {https://www.medrxiv.org/content/early/2021/03/30/2021.03.27.21254452}, eprint = {https://www.medrxiv.org/content/early/2021/03/30/2021.03.27.21254452.full.pdf}, journal = {medRxiv} }